1. Home
  2. LXRX vs FMAO Comparison

LXRX vs FMAO Comparison

Compare LXRX & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FMAO
  • Stock Information
  • Founded
  • LXRX 1995
  • FMAO 1897
  • Country
  • LXRX United States
  • FMAO United States
  • Employees
  • LXRX N/A
  • FMAO N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FMAO Savings Institutions
  • Sector
  • LXRX Health Care
  • FMAO Finance
  • Exchange
  • LXRX Nasdaq
  • FMAO Nasdaq
  • Market Cap
  • LXRX 428.8M
  • FMAO 358.1M
  • IPO Year
  • LXRX 2000
  • FMAO N/A
  • Fundamental
  • Price
  • LXRX $1.52
  • FMAO $24.97
  • Analyst Decision
  • LXRX Buy
  • FMAO
  • Analyst Count
  • LXRX 5
  • FMAO 0
  • Target Price
  • LXRX $3.23
  • FMAO N/A
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • FMAO 24.0K
  • Earning Date
  • LXRX 11-11-2025
  • FMAO 10-29-2025
  • Dividend Yield
  • LXRX N/A
  • FMAO 3.58%
  • EPS Growth
  • LXRX N/A
  • FMAO 38.39
  • EPS
  • LXRX N/A
  • FMAO 2.16
  • Revenue
  • LXRX $58,432,000.00
  • FMAO $108,632,000.00
  • Revenue This Year
  • LXRX $67.21
  • FMAO $3.38
  • Revenue Next Year
  • LXRX N/A
  • FMAO $6.39
  • P/E Ratio
  • LXRX N/A
  • FMAO $11.44
  • Revenue Growth
  • LXRX 1504.83
  • FMAO 13.86
  • 52 Week Low
  • LXRX $0.28
  • FMAO $20.88
  • 52 Week High
  • LXRX $2.18
  • FMAO $34.15
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 70.28
  • FMAO 45.86
  • Support Level
  • LXRX $1.28
  • FMAO $24.21
  • Resistance Level
  • LXRX $1.42
  • FMAO $26.45
  • Average True Range (ATR)
  • LXRX 0.10
  • FMAO 0.83
  • MACD
  • LXRX 0.02
  • FMAO -0.12
  • Stochastic Oscillator
  • LXRX 81.00
  • FMAO 33.48

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About FMAO Farmers & Merchants Bancorp Inc.

Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.

Share on Social Networks: